Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04431518 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics of JULUCA in Hemodialysis
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT04431518 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 8 participants.
The verdict
NCT04431518, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study will compare the pharmacokinetics of the component drugs in JULUCA, and HIV combination treatment pill, in HIV-negative patients who require hemodialysis with those with normal renal function.
Interventions
- DRUG JULUCA 50Mg-25Mg Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-04-23 |
| Est. Completion | 2023-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04431518
The ClinicalTrials.gov registry entry for NCT04431518 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JULUCA 50Mg-25Mg Tablet is the first listed.
NCT04431518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04431518 about?
NCT04431518 is a clinical study titled "Pharmacokinetics of JULUCA in Hemodialysis". This study will compare the pharmacokinetics of the component drugs in JULUCA, and HIV combination treatment pill, in HIV-negative patients who require hemodialysis with those with normal renal function.
What is the current status of trial NCT04431518?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2021-04-23. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT04431518?
The interventions under investigation include: JULUCA 50Mg-25Mg Tablet (DRUG).
Who is sponsoring clinical trial NCT04431518?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.